Vitamin E and total parenteral nutrition

Area of Science:

• Nutritional Biochemistry
• Clinical Nutrition
• Hematology

Background:

• Patients on total parenteral nutrition (TPN) are at risk for micronutrient deficiencies, including vitamin E and essential fatty acids.
• Vitamin E deficiency is linked to platelet hyperaggregation and red blood cell hemolysis, impacting patient health.
• Essential fatty acid deficiency (EFAD) can also occur during TPN, potentially causing similar hematological issues.

Purpose of the Study:

• To evaluate vitamin E and essential fatty acid status in patients undergoing TPN.
• To determine the efficacy of intravenous all-rac-alpha-tocopherol and intravenous fat emulsions in correcting deficiencies and associated abnormalities.
• To assess vitamin E requirements during TPN, particularly when fat-free or fat-containing emulsions are used.

Main Methods:

• Two groups of TPN patients were studied: one received fat-free TPN with vitamin E supplementation, the other received routine intravenous fat emulsions.
• Initial assessments included vitamin E levels, platelet aggregation, and in vitro hydrogen peroxide-induced hemolysis.
• Patients were monitored for changes in these parameters following supplementation or fat emulsion administration.

Main Results:

• A 50% incidence of vitamin E deficiency, platelet hyperaggregation, or hemolysis was observed initially.
• Platelet hyperaggregation significantly correlated with vitamin E deficiency.
• Intravenous all-rac-alpha-tocopherol corrected platelet and red blood cell abnormalities, suggesting higher vitamin E needs (25-50 mg/day or more) during TPN.
• Intravenous fat emulsions did not resolve these abnormalities, possibly due to increased vitamin E requirements or low alpha-tocopherol content.
• Essential fatty acid deficiency (EFAD) was found in seven patients with platelet hyperaggregation independent of vitamin E status.
• Prolonged TPN in three patients resulted in persistent EFAD and platelet hyperaggregation despite high weekly fat emulsion volumes.

Conclusions:

• Vitamin E supplementation is crucial for correcting platelet and red blood cell abnormalities in TPN patients.
• Standard intravenous fat emulsions may not adequately meet vitamin E requirements or correct associated deficiencies.
• Higher vitamin E dosages are likely necessary during TPN, especially with fat-free regimens or when using standard fat emulsions.
• Essential fatty acid deficiency can occur independently and contribute to platelet dysfunction in TPN patients.
• Further research is needed to optimize TPN protocols for micronutrient delivery, particularly vitamin E and essential fatty acids.